Variant report
Variant | esv17315 |
---|---|
Chromosome Location | chr16:76250287-76251108 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562883677 | chr16:76250330-76250331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537420295 | chr16:76250352-76250353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531880523 | chr16:76250390-76250391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554122697 | chr16:76250431-76250432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs16943993 | chr16:76250471-76250472 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs148259053 | chr16:76250480-76250481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185282938 | chr16:76250482-76250483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574503570 | chr16:76250495-76250496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577321861 | chr16:76250600-76250601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546093168 | chr16:76250648-76250649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377162283 | chr16:76250661-76250662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564499689 | chr16:76250668-76250669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142808653 | chr16:76250682-76250683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576661839 | chr16:76250765-76250766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548731308 | chr16:76250790-76250791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79589113 | chr16:76250825-76250826 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs72794923 | chr16:76250833-76250834 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs546868443 | chr16:76250878-76250879 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189019260 | chr16:76250942-76250943 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77131982 | chr16:76250996-76250997 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114229314 | chr16:76251011-76251012 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552108022 | chr16:76251037-76251038 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536483654 | chr16:76251040-76251041 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569062148 | chr16:76251075-76251076 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374769538 | chr16:76251082-76251083 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147473422 | chr16:76251093-76251094 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115445366 | chr16:76251098-76251099 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 24585490 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:76241600-76257400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr16:76249000-76254400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr16:76249600-76250800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr16:76249800-76250800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr16:76249800-76257400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr16:76250800-76251200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr16:76250800-76252000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |